Last quarter (Q3 2023), ENDRA Life Sciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, ENDRA Life Sciences's net income was $-3.10M. See ENDRA Life Sciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	-	-	-	$ 0.00	$ 0.00	$ 6.17K
Cost of Revenue	-	-	-	-	$ 0.00	$ 0.00
Gross Profit	-	-	-	$ 0.00	$ 0.00	$ 6.17K
Operating Expense	$ 5.75M	$ 13.16M	$ 11.50M	$ 11.50M	$ 10.84M	$ 8.74M
Operating Income	$ -12.37M	$ -13.16M	$ -11.50M	$ -11.50M	$ -10.84M	$ -8.73M
Net Non Operating Interest Income Expense	-	-	-	$ -232.43K	$ -2.36M	$ -729.24K
Other Income Expense	$ -6.69K	$ 21.53K	$ 471.22K	$ 8.84K	$ -106.90K	$ -335.55K
Pretax Income	$ -11.89M	$ -13.18M	$ -11.97M	$ -11.73M	$ -13.31M	$ -9.80M
Tax Provision	-	-	-	$ 0.00	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	$ -121.07K	-	-	-
Net Income Common Stockholders	$ -11.89M	$ -13.18M	$ -11.97M	$ -12.12M	$ -17.53M	$ -9.80M
Basic EPS	$ -4.56	$ -4.56	$ -5.60	$ -0.63	$ -2.34	$ -2.17
Diluted EPS	$ 0.07	$ -4.56	$ -5.60	$ -0.63	$ -2.34	$ -2.17
Basic Average Shares	$ 2.89M	$ 2.89M	$ 2.05M	$ 19.19M	$ 7.50M	$ 4.50M
Diluted Average Shares	-	$ 2.89M	$ 2.05M	$ 19.19M	$ 7.50M	$ 4.50M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 5.75M	$ 13.16M	$ 11.50M	$ 11.50M	$ 10.84M	$ 8.74M
Net Income From Continuing And Discontinued Operation	$ -11.89M	$ -13.18M	$ -11.97M	$ -11.73M	$ -13.31M	$ -9.80M
Normalized Income	$ -4.91M	$ -10.41M	-	$ -11.73M	$ -13.31M	$ -9.51M
Interest Expense	-	-	-	$ 232.43K	$ 2.36M	$ 729.24K
EBIT	$ -11.89M	$ -13.18M	$ -11.97M	$ -11.49M	$ -10.95M	$ -9.07M
EBITDA	$ -11.61M	$ -12.94M	$ -11.75M	$ -11.33M	$ -10.84M	$ -9.00M

Currency in USD

ENDRA Life Sciences Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing